Photo via New York Post

White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback

Read the original at New York Post ↗
Cite

Nava, V. (2026, November 18). White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback. New York Post. https://nypost.com/2026/11/17/us-news/white-house-withdraws-heidi-overtons-fda-bid-after-nominee-received-bipartisan-pushback/

Dated from the outlet's own feed. Check the original for its byline.

New York Post · collected 2026-11-18 · by Victor Nava

Quick Summary

The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration (FDA) due to insufficient support from Senate lawmakers. Overton, a physician and deputy director of the White House Domestic Policy Council, faced significant opposition for her alleged ties to the tobacco industry, pro-vaping stance, and anti-abortion views. Critics demonstrated their disapproval by placing signs around Capitol Hill, including one that reads, “Say no to Heidi Vaperton,” with a crossed-out image of Overton holding a vape device.
Written by AI on 2026-11-18, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

AI analysis

Story summary

The White House withdrew Dr. Heidi Overton’s nomination to lead the Food and Drug Administration (FDA) on November 17, 2026, just before a scheduled Senate committee vote, due to lack of bipartisan support. Overton faced skepticism from some Republicans over her involvement in the administration's efforts to change childhood vaccine recommendations. To advance to the full Senate, Overton needed 11 votes from the 21-member committee, but she failed to secure the necessary Republican support. The decision leaves the FDA’s leadership vacancy unresolved, with Senate Democrats now likely to take the lead in selecting a new nominee.

Written for “White House Withdraws Heidi Overton’s FDA Nomination” on 2026-11-21, grounded in this article and the 16 other(s) covering the same event.

How they differ

13 outlets covered “White House Withdraws Heidi Overton’s FDA Nomination”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

New York PostThis outlet18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration (FDA) due to insufficient support from Senate lawmakers. Overton, a physician and deputy director of the White House Domestic Policy Council, faced significant opposition for her alleged ties to the tobacco industry, pro-vaping stance, and anti-abortion views. Critics demonstrated their disapproval by placing signs…

White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback (this article)
Semafor19 Nov

The FDA is facing a leadership gap as the White House has withdrawn Heidi Overton's nomination, likely preventing a replacement before the end of the year. This situation could lead to a series of temporary commissioners, such as Sara Brenner or Karim Mikhail, overseeing the agency's operations. The lack of a permanent leader complicates efforts to secure industry user fees, which provide half of the FDA’s funding…

FDA's long-term vacancy →3 articles from Semafor on this story
CBS News18 Nov

The White House has withdrawn Dr. Heidi Overton's nomination as the new FDA commissioner, a position she was selected for by President Trump. The Senate health committee was set to vote on her nomination on Wednesday, but the White House has since decided to remove her from consideration. Axios was the first to report this change.

White House drops Heidi Overton's nomination for FDA commissioner →2 articles from CBS News on this story
Fox News20 Nov

Erik Baptist, senior vice president of legal strategy at Susan B. Anthony Pro-Life America, told Fox News Digital that his organization pushed for the Senate to delay Heidi Overton's nomination to head the FDA until the Trump administration committed to ending mail-order access to abortion drugs and changing how the FDA studies the safety of those drugs. Baptist emphasized that pro-life states cannot enforce their…

Pro-life group says Trump admin didn't give key abortion drug commitments before Overton FDA nomination pulled →2 articles from Fox News on this story
The Straits Times18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the US Food and Drug Administration (FDA) before her confirmation hearing, according to Axios. The decision was made due to a lack of congressional support, especially after criticism from a former Health Secretary’s adviser and opposition from several Republican senators. This move adds to the FDA’s ongoing leadership challenges, with the agency…

White House pulls FDA chief nominee Heidi Overton before hearing, Axios says →
Toronto Star18 Nov

The White House has withdrawn Dr. Heidi Overton’s nomination to lead the Food and Drug Administration due to insufficient Senate Republican support. Overton, a Trump-aligned physician and White House domestic policy adviser, was nominated in August to replace Dr. Marty Makary, who had a controversial tenure. Her nomination was intended to stabilize the FDA with a Trump loyalist, but faced opposition that prevented…

White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans →
Show 7 more outlets
NBC News18 Nov

The White House has withdrawn Dr. Heidi Overton’s nomination to become the FDA commissioner due to Republican senators' concerns about her lack of managerial experience. The decision came shortly before Overton’s scheduled Senate Health Committee vote, where she needed at least one Republican vote to advance. Senators Cassidy, Collins, and Murkowski expressed reservations about Overton’s qualifications and her…

White House drops Heidi Overton’s FDA nomination →
ABC News (US)18 Nov

Dr. Heidi Overton's nomination to become the FDA commissioner was withdrawn on Tuesday after facing significant opposition from some Republican senators. The nomination encountered hurdles primarily due to Overton’s positions on abortion, vaccines, and vaping, according to sources familiar with the situation.

Trump's pick Heidi Overton dropped as nominee for FDA commissioner →
Just the News18 Nov

The White House has withdrawn Heidi Overton's nomination to lead the Food and Drug Administration (FDA) just one day before her scheduled vote by the Senate Health, Education, Labor and Pensions Committee. Overton, a physician and deputy director of the White House Domestic Policy Council, faced skepticism from some Republicans about her involvement in changing childhood vaccine recommendations. A senior…

White House pulls Heidi Overton's nomination to lead Food and Drug Administration: Report →
The Guardian18 Nov

The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration after bipartisan concerns about her willingness to challenge President Trump’s policies, particularly regarding vaccines and abortion. Republican senator Bill Cassidy, who chairs the Senate health committee, had expressed reservations about her support for Trump’s vaccine plans and her stance on abortion rights…

White House withdraws nomination of Heidi Overton to lead FDA →
Daily Caller18 Nov

The Trump administration withdrew Heidi Overton’s nomination to lead the FDA on November 18, 2026, due to lack of support in the Senate. Overton, a physician and deputy director of the White House Domestic Policy Council, was nominated in August and faced opposition from Democrats, some Republicans, and MAHA activists. The White House cited the need for a more populist approach to health as the reason for the…

MAHA Rejoices After White House Drops Controversial FDA Nomination →
The Independent18 Nov

The White House has withdrawn Dr. Heidi Overton’s nomination to lead the Food and Drug Administration (FDA) just before a Senate committee vote scheduled for Wednesday. Overton, a physician with a history of opposing abortion, faced significant opposition from pro-life senators like Josh Hawley, as well as from senators like Susan Collins and Lisa Murkowski over her stance on abortion and her role in approving…

White House pulls Trump’s FDA nominee on eve of key Senate vote →

Where they agree and split

Framing

How the first headlines put it

Attributed to a source2
Stated as fact10
The headlines (12)

White House pulls FDA chief nominee Heidi Overton before hearing, Axios says The Straits Times · attributed to a source

White House pulls Heidi Overton's nomination to lead Food and Drug Administration: Report Just the News · attributed to a source

Trump administration weighs Marshall for FDA as Overton wobbles Semafor · stated as fact

Trump FDA nominee Heidi Overton struggling to win GOP support CBS News · stated as fact

White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback New York Post · stated as fact

White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans Toronto Star · stated as fact

White House drops Heidi Overton’s FDA nomination NBC News · stated as fact

White House pulls Trump’s FDA pick Heidi Overton on eve of Senate panel vote Fox News · stated as fact

Trump's pick Heidi Overton dropped as nominee for FDA commissioner ABC News · stated as fact

White House withdraws nomination of Heidi Overton to lead FDA The Guardian · stated as fact

White House withdraws Heidi Overton’s nomination to become next FDA commissioner Washington Examiner · stated as fact

MAHA Rejoices After White House Drops Controversial FDA Nomination Daily Caller · stated as fact

The full story: what happened, how it changed, and all 17 articles →

Compared with similar articles

This article reads leans left and hedges 0% of its claims. Each row says how that neighbour differs.
The Straits Times
Hedges 3 of 17 claims Outlet record 64/100
The Independent
Leans right further right than this Hedges 6 of 23 claims Outlet record 59/100
Washington Examiner
Hedges 0 of 2 claims Outlet record 67/100
NBC News
Leans right further right than this Hedges 1 of 19 claims Outlet record 74/100
CBS News
Hedges 1 of 4 claims Outlet record 66/100
ABC News (US)
Leans right further right than this Hedges 0 of 4 claims Outlet record 66/100
The Daily Caller
Hedges 4 of 27 claims Outlet record 92/100
Toronto Star
Leans right further right than this Hedges 0 of 3 claims Outlet record 65/100
The Guardian
Leans right further right than this Hedges 1 of 18 claims Outlet record 64/100
Semafor
Hedges 3 of 8 claims Outlet record 64/100

Story

White House Withdraws Heidi Overton’s FDA Nomination
Politics · 17 article(s) covering the same event. Compare every outlet's account →
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
7
sentences that state something as happening or true
Uncertain
0%
0 of 7 hedged ("reportedly", "may", "according to")
Leaning
Leans left
of the writing, not the subject · beta estimate
Publisher signals
66/100
New York Post's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
17
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-18 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

New York Post · 21831 article(s) · 42 correction(s) detected
Running correction rate · 42 correction(s)

Who wrote this

Victor Nava
98 article(s) here · 0 carrying a prediction
It’s unclear if the FBI has an inkling of who may be responsible for the cyber attack, but the bureau was targeted in September by a digital extortion group known as “ShinyHunters.”
“If the tracks were faked, someone went to a great deal of trouble and detail,” Johnson wrote, noting that some of the print marks on the feet “would have to be very hard to duplicate” and “appear very natural.”
The first lady then joked that her husband, President Trump, would probably just want to play a round of golf on Christmas Day.
A technical bulletin obtained by the outlet further stated that USDA applications “may continue to experience intermittent outages throughout the week” as maintenance continues.
“I think that collapse will be inevitable if you keep the pressure up … the three legs: credible military threat, crippling sanctions, and to engage the Iranian people as your partners will put tremendous, tremendous pressure on them,” Dermer said.
Peltola’s victory will give Democrats a 56-44 seat advantage over Republicans come January.
Asked about the role artificial intelligence might have played in the outages, Rubio said he didn’t want to speculate.
Officials seem divided over how credible the intelligence is, and whether Tehran could pull off such an attack, which appears to be aimed at taking out top Trump administration officials in Washington, DC, CNN reported Monday.
Biden said the prosecution “failed to break Hunter,” before adding, “But I would be lying if I didn’t admit that they took a piece out of me.” The former president said the Atlanta debate — which took place 16 days after Hunter was found guilty of lying about his drug addiction on federal forms when he purchased a firearm — “didn’t feel right from the start.”
The DCCC, which is the campaign arm for House Democrats, said the probe would be “swift, thorough and transparent,” and that it would have further comment once the investigation is completed.
Also by Victor Nava
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 98 articles by Victor Nava →

Topics

FDA Hill Senate the Food and Drug Administration the White House

Subjects

Overton PERSON · 3× FDA ORG · 2× Axios ORG · 1× Heidi Overton PERSON · 1× Heidi Overton’s PERSON · 1× Hill ORG · 1× Senate ORG · 1× White House ORG · 1× the Food and Drug Administration ORG · 1× the White House ORG · 1×

Narrative

Heidi Overton’s nomination to lead the Food and Drug Administration (FDA) has been withdrawn by the White House on the eve of her confirmation vote after she failed to win over enough support from Senate lawmakers.
framing: assertive · carried by 1 article(s) · first seen 2026-11-18

Claims (7 extracted, 0 hedged)

Heidi Overton’s nomination to lead the Food and Drug Administration (FDA) has been withdrawn by the White House on the eve of her confirmation vote after she failed to win over enough support from Senate lawmakers. asserted
she → lead → lawmakers
“FDA nominee Heidi Overton lacks the support on the Hill to move forward with her confirmation,” a senior administration official told Axios Tuesday. asserted
official → lack → Axios
A White House official confirmed with The Post that Overton’s nomination was pulled. asserted
nomination → confirm → Post
Overton, a physician and deputy director of the White House Domestic Policy Council, has faced criticism for her alleged “big tobacco ties,” support for vaping and anti-abortion stance. asserted
Overton → face → vaping
As part of an apparent effort to thwart her nomination, anti-Overton signs have appeared all over Capitol Hill in recent days. asserted
signs → thwart → days
Advertisement “Say no to Heidi Vaperton,” reads one sign, which includes a crossed-out photo of Overton holding a vape. asserted
which → say → vape
This is a developing story. asserted
This → develop → ?
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support